Prof. Jan focuses on the synthesis and self-assembly of amphiphilic polypeptides and glycopeptides. These self-assembled structures can have potential applications in biomedical field such as drug delivery and encapsulation. They possess essential structures and functions of proteins that can mimic the biological activities and supramolecular structures of natural proteins. He is also interested in the biomimetic or bio-inspired synthesis of inorganic nanomaterials.

Prof. Ertl has been developing miniaturized analysis systems for a number of years, including lab-on-a-chip systems containing integrated electro- analytical (AMP, ECIS), magnetic (GMR) and optical (OPD) detection methods to continuously monitor blood glucose concentrations, viral contaminations, stem cell fitness, cancer interactions with tissue and immune cells, as well as nanoparticle uptake rates by various tissue types. Another focus of my research group for some years has been the combination of liquid handling systems, electronic components and sensory systems to develop next generation diagnostic devices for biomedical applications. Our latest cell chip system, for instance, consists of computer controlled and pneumatically-activated pumps and valves, degassers and a biochip containing embedded sensor arrays as well as electronic read out. This diagnostic platform can perform a variety of tasks including sample loading, rinsing and washing steps, reagent addition at specific concentrations and gradients, as well as multilevel cell analysis.

Prof. Lin focuses to use molecularly imprinted polymers (MIPs) as recognition elements in sensing applications, or for the controlled delivery of small molecule drugs. He uses MIPs in the binding and immobilization of active enzymes. Recently, he synthesizes magnetic/optical MIPs by using phase inversion of poly(ethylene-co-vinyl alcohol) or chitosan. He demonstrates that magnetic molecularly imprinted nanoparticles have the advantages of high surface area, suspension, easy removal from reaction and rapid reload of bioactive molecules (e.g. Cas9).

Prof. Luo's research interest is the behaviors of organic and polymeric materials in aqueous environment. Research targets include conductive organic materials, conducting polymers, and stimuli-responsive materials. We start from the design of building blocks, synthesis, characterization to device assembly. In addition to investigating the nature of between the structures and properties of materials, we focus on how molecules and materials response to the environmental change in aqueous solutions. These materials are used for bioanalysis, bioelectronics and other bioengineering applications.

Prof. Deli is a research professor and group leader at the Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences. Mária does research in Toxicology, Pharmacy and Cell Biology fields with special focus on biological barriers. Her team investigates new methods to increase drug delivery across the gut, nasal, respiratory and blood-brain barriers by targeted nanoparticles and also with modulation of the intercellular junctions. Another major research field of the group is barrier dysfunction in diseases, and barrier protection as a therapeutical target. The

The Barenholz's Lab focuses on research and application of liposomes based drugs from basic aspects of design of the drug carriers through animal studies and clinical trials, on the way to, FDA-approved drugs. The lab is involved in broad spectrum of projects divided in two main categories. One, Local delivery based on various kinds of large multi-lamellar liposomal vesicles to treat osteoarthritis and large multivesicular vesicles having high trapped volume for local delivery of low and high molecular weight active pharmaceutical ingredients. The second category is based on the use of nano-liposomes for systemic treatments. They also developed novel injectable nano-drug delivery systems, based on pegylated long circulating nano-sterically stabilized liposomes.

Dr. Turjeman is the expert of the liposome-based drug carriers. She focuses on the liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases. Currently, She also develops a anti‐inflammatory agents which is the steroidal nanodrugs based on pegylated nanoliposomes remote loaded with amphipathic weak acids steroid prodrugs.